Does temporary extracorporeal life support improve survival in patients with cardiogenic shock due to refractory arrhythmic storm?
Extracorporeal life support provides efficient hemodynamic support with a 50% survival rate in patients with cardiogenic shock due to refractory arrhythmic storm.
This is the largest database of patients temporary implanted with extracorporeal life support for refractory arrhythmic storm responsible for cardiogenic shock resistant to antiarrhythmic drugs. It provides efficient hemodynamic support and survival rate after the implantation is 50%.
Pennec-Prigent et al. (Sat,) studied this question.